April 3, 2014
Corium International, Inc. Announces Pricing of Initial Public Offering
MENLO PARK, Calif., April 3, 2014 /PRNewswire/ — Corium International, Inc. (NASDAQ: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today the pricing of its initial public offering of 6,500,000 shares of common stock at a price to the public of $8.00 per share. The shares are scheduled to begin trading on the NASDAQ Stock Market on April 3, 2014 under the symbol “CORI”. All of the shares of common stock are being offered by Corium. Corium has also granted the underwriters a 30-day option to purchase up to 975,000 additional shares of common stock at the initial public offering price.